Patient Story: Robotic Uterine Fibroid Embolization with Magellan Hansen Medical Inc 2:28 9 years ago 2 263 Далее Скачать
Managing patients with triple-class exposed myeloma using combination therapies VJHemOnc – Video Journal of Hematology & HemOnc 1:52 1 month ago 20 Далее Скачать
Assessing financial toxicity of CAR-T therapy in myeloma and improving access to this treatment VJHemOnc – Video Journal of Hematology & HemOnc 1:46 2 days ago 79 Далее Скачать
Dr Fatemeh Moheimani and Dr Laurence Pearmain - 2024 HC Roscoe grant winners BMA Foundation 1:54 3 weeks ago 32 Далее Скачать
Comparing real-world outcomes and toxicities with commercial axi-cel and tisa-cel for R/R FL VJHemOnc – Video Journal of Hematology & HemOnc 2:01 9 hours ago 9 Далее Скачать
CARTITUDE-1: outcomes of patients with triple-class exposed multiple myeloma treated with cilta-cel VJHemOnc – Video Journal of Hematology & HemOnc 1:25 1 year ago 107 Далее Скачать
VT3989YAP, a YAP/TEAD inhibitor, in mesothelioma and NF2-mutant cancers VJOncology 1:05 1 year ago 1 346 Далее Скачать
The recent FDA approval of cilta-cel and its impact on myeloma patients in the UK VJHemOnc – Video Journal of Hematology & HemOnc 1:12 2 years ago 145 Далее Скачать
FIRE-6: avelumab + FOLFIRI plus cetuximab followed by avelumab maintenance in untreated RASwt mCRC VJOncology 1:49 2 years ago 100 Далее Скачать
Black women 2-3x more likely to face uterine fibroids diagnosis FOX 61 4:17 2 years ago 257 Далее Скачать
LIGHTHOUSE: A phase 3 study of melflufen in combination with dex and daratumumab vs dara in RRMM pts International Myeloma Foundation 3:10 3 years ago 165 Далее Скачать
Advances in Medical Options for Uterine Fibroids and Endometriosis PeerView CME 30:13 5 years ago 1 019 Далее Скачать
Triplet Therapy, Transplantation, and Maintenance in Myeloma | NEJM NEJM Group 2:01 2 years ago 1 594 Далее Скачать
Long term follow-up results from the Phase III MAIA trial in myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:08 3 years ago 243 Далее Скачать